How much profit has Biomx made this year?
Biomx has made -44.73 M USD this year.
Biomx Net Income 2024
Biomx Net Income
-44.73 M USD
Ticker
PHGE
ISIN
US09090D1037
WKN
A2P9A0
In 2024, Biomx's profit amounted to -44.73 M USD, a 70.94% increase from the -26.17 M USD profit recorded in the previous year.
The Biomx Net Income history
| YEAR | NET INCOME (undefined USD) |
|---|---|
| 2029e | -6,664.17 |
| 2028e | -5,294.82 |
| 2027e | -5,842.56 |
| 2026e | -50,209.5 |
| 2025e | -47,470.8 |
| 2024e | -44,732.1 |
| 2023 | -26,169 |
| 2022 | -28,320 |
| 2021 | -36,230 |
| 2020 | -30,090 |
| 2019 | -20,560 |
| 2018 | 350 |
| 2017 | - |
Biomx Revenue, EBIT, Net Income US09090D1037 · A2P9A0
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Biomx, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Biomx from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Biomx’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Biomx. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Biomx’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Biomx’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Biomx’s growth potential.
Biomx Revenue, EBIT and net profit per share
| Date | Biomx Revenue | Biomx EBIT | Biomx Net Income |
|---|---|---|---|
| 2029e | 43.14 M undefined | 0 undefined | -6.66 M undefined |
| 2028e | 4.69 M undefined | -55.25 M undefined | -5.29 M undefined |
| 2027e | 0 undefined | -56.24 M undefined | -5.84 M undefined |
| 2026e | 0 undefined | -46.14 M undefined | -50.21 M undefined |
| 2025e | 0 undefined | -39.2 M undefined | -47.47 M undefined |
| 2024e | 0 undefined | -34.41 M undefined | -44.73 M undefined |
| 2023 | 0 undefined | -25.35 M undefined | -26.17 M undefined |
| 2022 | 0 undefined | -27.22 M undefined | -28.32 M undefined |
| 2021 | 0 undefined | -35.46 M undefined | -36.23 M undefined |
| 2020 | 0 undefined | -30.26 M undefined | -30.09 M undefined |
| 2019 | 0 undefined | -22.21 M undefined | -20.56 M undefined |
| 2018 | 0 undefined | -400,000 undefined | 350,000 undefined |
| 2017 | 0 undefined | 0 undefined | 0 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2017 | 0 USD | 0 USD | 0 USD |
| 2018 | 0 USD | -400,000 USD | 350,000 USD |
| 2019 | 0 USD | -22.21 M USD | -20.56 M USD |
| 2020 | 0 USD | -30.26 M USD | -30.09 M USD |
| 2021 | 0 USD | -35.46 M USD | -36.23 M USD |
| 2022 | 0 USD | -27.22 M USD | -28.32 M USD |
| 2023 | 0 USD | -25.35 M USD | -26.17 M USD |
| 2024e | 0 USD | -34.41 M USD | -44.73 M USD |
| 2025e | 0 USD | -39.2 M USD | -47.47 M USD |
| 2026e | 0 USD | -46.14 M USD | -50.21 M USD |
| 2027e | 0 USD | -56.24 M USD | -5.84 M USD |
| 2028e | 4.69 M USD | -55.25 M USD | -5.29 M USD |
| 2029e | 43.14 M USD | 0 USD | -6.66 M USD |
Biomx stock margins US09090D1037 · A2P9A0
The Biomx margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Biomx. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Biomx.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Biomx's sales revenue. A higher gross margin percentage indicates that the Biomx retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Biomx's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Biomx's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Biomx's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Biomx. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Biomx's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Biomx Margin History
| Biomx Gross margin | Biomx Profit margin | Biomx EBIT margin | Biomx Profit margin |
|---|---|---|---|
| 2029e | 0 % | 0 % | -15.45 % |
| 2028e | 0 % | -1,177.52 % | -112.85 % |
| 2027e | 0 % | 0 % | 0 % |
| 2026e | 0 % | 0 % | 0 % |
| 2025e | 0 % | 0 % | 0 % |
| 2024e | 0 % | 0 % | 0 % |
| 2023 | 0 % | 0 % | 0 % |
| 2022 | 0 % | 0 % | 0 % |
| 2021 | 0 % | 0 % | 0 % |
| 2020 | 0 % | 0 % | 0 % |
| 2019 | 0 % | 0 % | 0 % |
| 2018 | 0 % | 0 % | 0 % |
| 2017 | 0 % | 0 % | 0 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2017 | 0 % | 0 % | 0 % |
| 2018 | 0 % | 0 % | 0 % |
| 2019 | 0 % | 0 % | 0 % |
| 2020 | 0 % | 0 % | 0 % |
| 2021 | 0 % | 0 % | 0 % |
| 2022 | 0 % | 0 % | 0 % |
| 2023 | 0 % | 0 % | 0 % |
| 2024e | 0 % | 0 % | 0 % |
| 2025e | 0 % | 0 % | 0 % |
| 2026e | 0 % | 0 % | 0 % |
| 2027e | 0 % | 0 % | 0 % |
| 2028e | 0 % | -1,177.52 % | -112.85 % |
| 2029e | 0 % | 0 % | -15.45 % |
Biomx Aktienanalyse
What does Biomx do?
Biomx Inc is a biotech company specializing in the development of bacterial therapies for the treatment of neurological and metabolic disorders. The company was founded in 2015 in Israel and has since moved its headquarters to San Francisco. Biomx's business model is based on the discovery, isolation, and characterization of bacterial strains associated with specific diseases, and the development of therapies that can target and eliminate these bacteria. The company employs a combination of cutting-edge genomic, proteomic, and bioinformatic technologies to identify and analyze new bacterial species and strains. Biomx has two main areas of focus. The first is the development of bacteriophages (viruses that infect and destroy bacteria) that specifically target certain bacterial species associated with particular diseases. This includes the Colorectal Cancer program, which aims to develop bacterial therapies for the treatment of colon cancer. The second area is the development of bacterial therapies targeting specific pathogens. One potential therapy that could be developed in the future, for example, is one that targets the bacterium Helicobacter pylori, which can cause stomach ulcers and stomach cancer. Biomx has also formed partnerships with other leading biopharmaceutical companies to utilize its technology platforms and develop bacterial therapies. Biomx has several promising products in its pipeline, including BX002, a bacteriophage product for the treatment of acute diarrhea caused by Clostridium difficile, CX002, a bacterial product for the treatment of acute respiratory failure, and a program for the development of bacterial therapies for the treatment of Crohn's disease. Overall, Biomx has played a significant role in the development of new methods for disease treatment in recent years and is expected to continue to be a key player in the biotechnology industry in the future. Biomx ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Biomx's Profit Margins
The profit margins of Biomx represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Biomx's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Biomx's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Biomx's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Biomx’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Biomx stock
How has the profit developed compared to last year?
The profit has increased by 70.94% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Biomx publish its earnings?
Biomx publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Biomx?
The profits of Biomx are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Biomx?
You can learn more about the earnings of Biomx by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Biomx pay?
Over the past 12 months, Biomx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biomx is expected to pay a dividend of 0 USD.
What is the dividend yield of Biomx?
The current dividend yield of Biomx is .
When does Biomx pay dividends?
Biomx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Biomx?
Biomx paid dividends every year for the past 0 years.
What is the dividend of Biomx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Biomx located?
Biomx is assigned to the 'Health' sector.
Wann musste ich die Aktien von Biomx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Biomx from 11/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/16/2024.
When did Biomx pay the last dividend?
The last dividend was paid out on 11/16/2024.
What was the dividend of Biomx in the year 2023?
In the year 2023, Biomx distributed 0 USD as dividends.
In which currency does Biomx pay out the dividend?
The dividends of Biomx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Biomx
Our stock analysis for Biomx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biomx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
